101 Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| 101-PGC-005 for the Treatment of COVID-19 (NCT05656521) | 101 Therapeutics | 2023-01-31 |
| Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects (NCT05619770) | 101 Therapeutics | 2022-10-29 |
| A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care (NCT05195749) | 101 Therapeutics | 2022-01-13 |
Track 101 Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.